期刊文献+

前列腺特异性启动子rPB的改造及其载体质粒的构建和活性测定 被引量:4

Construction and activity determination of modified prostatic specific promoters rPB-DRs
下载PDF
导出
摘要 目的 构建一个前列腺特异性的、可启动针对雄激素非依赖性前列腺癌的基因治疗的改良启动子并测定其活性。方法 选择前列腺特异性启动子rPB ,通过两次PCR对其进行改造,用维甲酸反应元件(RARE)替代雄激素反应元件(ARE)或直接插入RARE ,构建成为不同拷贝条件的rPB DR ,并与质粒连接。转染细胞后,进行荧光素酶活性测定。结果 通过电泳鉴定及基因测序,证实构建成功。结论 根据实验设计,构建出的rPB DR应具有在维甲酸的调控下,针对雄激素非依赖性前列腺癌特异性启动基因治疗的功能,现构建成功不同拷贝条件的rPB DR ,证实实验设计构想,同时通过活性测定比较各种拷贝条件的rPB DR启动子活性的优劣,为下一步与治疗基因的连接及功能测定奠定基础。 Objective To construct the prostatic specific promoter used to induce the gene therapy aiming at androgen independent prostatic carcinoma and evaluate the activity. Methods Through two steps of polymerase chain reaction (PCR), androgen response elements (AREs) in rPB were replaced by synthetic retinoic acid response elements (RAREs). Then the modified rPBs were connected with the plasmid. The activity was evaluated. Results Constructions were confirmed to be successful by electrophoresis and gene sequencing. Conclusion Modified rPB should be the prostatic specific promoter which can induce the gene therapy aiming at androgen-independent prostatic carcinoma controlled by retinoic acid. After being constructed, the modified rPBs were used to confirm our ideas about the experiment design and the capability inducing the gene expression of different modified rPBs was compared.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第10期981-984,共4页 Journal of Third Military Medical University
基金 重庆市科委攻关课题 ( 2 0 0 3 2 0 0 5)~~
关键词 前列腺癌 雄激素非依赖 基因治疗 启动子 维甲酸反应元件 prostatic neoplasm androgen independent gene therapy promoter retinoic acid response element
  • 相关文献

参考文献5

  • 1江军,王洛夫,方玉华,靳风烁,靳文生,李彦锋.雄激素受体反义RNA对前列腺癌细胞雄激素受体表达的抑制作用研究[J].第三军医大学学报,2003,25(6):501-504. 被引量:11
  • 2Eastham J A,Chen S H,Sehgal I,et al.Prostate cancer gene therapy:herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models[J].Hum Gene Ther,1996,7(4):515-523.
  • 3Blackburn R V,Galoforo S S,Corry P M,et al.Adenoviral-mediated transfer of heat-inducible double suicide gene into prostate carcinoma cells[J].Cancer Res,1998,58(7):1358-1362.
  • 4Koshiuka K,Elstner E,Williamson E,et al.Novel therapeutic approach:organic arsenical melarsoprol alone or with all-trans-retinoic acid markedly inhibits growth of human breast and prostate cancer cells in vitro and in vivo[J].Br J Cancer,2000,82(2):452-458.
  • 5Jiang G,Sladek F M.The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative,specific binding to DNA and heterodimerization with the retinoid X receptor alpha[J].J Biol Chem,1997,272(2):1218-1225.

二级参考文献3

共引文献10

同被引文献23

  • 1Schrijvers D. Androgen-independent prostate cancer[ J]. Recent Resuits Cancer Res, 2007, 175 : 239 -249.
  • 2Singh P, Uzgare A, Litvinov I, et al. Combinatorial androgen receptor targeted therapy for prostate cancer [ J]. Endocr Retat Cancer, 2006, 13(3) : 653 -666.
  • 3Iversen P L, Arora V, Acker A J, et al. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase 1 safety study in humans[ J]. Clin Cancer Res, 2003, 9 (7) : 2510 -2519.
  • 4Essand M. Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies [ J ]. Acta Oncol, 2005, 44 ( 6 ) : 610 - 627.
  • 5Lee S J, Kim H S, Yu R, et al. Novel prostate-speeifie promoter derived from PSA and PSMA enhancers[J]. Mol Ther, 2002, 6(3) : 415 -421.
  • 6MATUO Y,NISHI N,NEGI T,et al.Isolation and characterization of androgen-dependent non-histone chromosomal protein from dorsolateral prostate of rats[J].Biochem Biophys Res Commun,1982,109 (2):334-340.
  • 7MATUSIK R J,KREIS C,MCNICOL P,et al.Regulation of prostatic genes:role of androgens and zinc in gene expression[J].Biochem Cell Biol,1986,64(6):601 -607.
  • 8DODD J G,SHEPPARD P C,MATUSIK R J.Characterization and cloning of rat dorsal prostate mRNAs.Androgen regulation of two closely related abundant mRNAs[J].J Biol Chem,1983,258 (17):10731-10737.
  • 9GREENBERG N M,DEMAYO F J,SHEPPARD P C,et al.The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice[J].Mol Endocrinol,1994,8(2):230-239.
  • 10IDE H,OSADA Y,YOSHIDA T,et al.Evaluation of prostate-specific promoters for a suicide gene therapy of prostate cancer[J].Nishinihon J Urol,1999,57:412 -417.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部